104 related articles for article (PubMed ID: 17045538)
1. Ventricular septal rupture following abciximab infusion.
Arnold JR; Timperley J; Mitchell AR; Westaby S; Ormerod O
Eur J Echocardiogr; 2008 Jan; 9(1):60-2. PubMed ID: 17045538
[TBL] [Abstract][Full Text] [Related]
2. Free wall rupture following rescue angioplasty and intravenous abciximab for failed thrombolysis.
Balachandran KP; Oldroyd KG
Scott Med J; 2001 Jun; 46(3):87-8. PubMed ID: 11501328
[TBL] [Abstract][Full Text] [Related]
3. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
Valgimigli M; Campo G; Percoco G; Bolognese L; Vassanelli C; Colangelo S; de Cesare N; Rodriguez AE; Ferrario M; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Parrinello G; Ferrari R;
JAMA; 2008 Apr; 299(15):1788-99. PubMed ID: 18375998
[TBL] [Abstract][Full Text] [Related]
4. Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.
Lenderink T; Boersma E; Ruzyllo W; Widimsky P; Ohman EM; Armstrong PW; Wallentin L; Simoons ML;
Am Heart J; 2004 May; 147(5):865-73. PubMed ID: 15131544
[TBL] [Abstract][Full Text] [Related]
5. Abciximab and fatal pulmonary hemorrhage.
Usman MH; Shah MA; ul-Islam T; Adenwalla HN; Rahman F; Baqir M; Altaf M; Venkataraman R; Cherayil M; Berger S
Heart Lung; 2006; 35(6):423-6. PubMed ID: 17137944
[TBL] [Abstract][Full Text] [Related]
6. Bleeding complications of platelet glycoprotein IIb/IIIa inhibitor abciximab (ReoPro ).
Trivedi SM; Shani J; Hollander G
J Invasive Cardiol; 2002 Jul; 14(7):423-5. PubMed ID: 12082199
[TBL] [Abstract][Full Text] [Related]
7. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial.
Ellis SG; Armstrong P; Betriu A; Brodie B; Herrmann H; Montalescot G; Neumann FJ; Smith JJ; Topol E;
Am Heart J; 2004 Apr; 147(4):E16. PubMed ID: 15077099
[TBL] [Abstract][Full Text] [Related]
8. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study.
Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Gaudreault V; Proulx G; Barbeau G; Déry JP; Gleeton O; Manh-Nguyen C; Noël B; Roy L; Costerousse O; De Larochellière R;
Am J Cardiol; 2010 Jun; 105(11):1520-7. PubMed ID: 20494655
[TBL] [Abstract][Full Text] [Related]
10. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
[TBL] [Abstract][Full Text] [Related]
11. Abciximab, eptifibatide, and tirofiban: comparison of parenteral glycoprotein IIb/IIIa inhibitors.
Dunn A
Conn Med; 1999 Aug; 63(8):483-7. PubMed ID: 10500344
[No Abstract] [Full Text] [Related]
12. Early abciximab administration in acute myocardial infarction treated with primary coronary intervention.
Bellandi F; Maioli M; Leoncini M; Toso A; Dabizzi RP
Int J Cardiol; 2006 Mar; 108(1):36-42. PubMed ID: 15927285
[TBL] [Abstract][Full Text] [Related]
13. Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction.
Jong P; Cohen EA; Batchelor W; Lazzam C; Kreatsoulas C; Natarajan MK; Strauss BH
Am Heart J; 2001 Feb; 141(2):218-25. PubMed ID: 11174335
[TBL] [Abstract][Full Text] [Related]
14. Profound thrombocytopenia caused by abciximab infusion following.
Daley B; Miranda D; Kalra A; Pease D
Minn Med; 2014 Oct; 97(10):48-9. PubMed ID: 25651641
[No Abstract] [Full Text] [Related]
15. Comparison between glycoprotein IIb/IIIa blockade and distal protection device for the restoration of myocardial perfusion during percutaneous coronary intervention for acute myocardial infarction.
Mak KH; Phay C; Wong A; Kwok V; Tan KS; Lau KW; Koh TH
J Invasive Cardiol; 2004 Dec; 16(12):694-8. PubMed ID: 15596872
[TBL] [Abstract][Full Text] [Related]
16. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.
Brener SJ; Maehara A; Dizon JM; Fahy M; Witzenbichler B; Parise H; El-Omar M; Dambrink JH; Mehran R; Oldroyd K; Gibson CM; Stone GW
JACC Cardiovasc Interv; 2013 Jul; 6(7):718-24. PubMed ID: 23866184
[TBL] [Abstract][Full Text] [Related]
17. Rheolytic therapy combined with intragraft abciximab for treatment in acute myocardial infarction.
Vallakati A; Mastrine L; Ayzenberg S
J Invasive Cardiol; 2013 Feb; 25(2):E33-5. PubMed ID: 23388236
[TBL] [Abstract][Full Text] [Related]
18. Severe hypotension complicating primary angioplasty: allergy to abciximab.
Hawkins C; Gatenby P; McGill D
Allergy; 2003 Jul; 58(7):688-9. PubMed ID: 12823141
[No Abstract] [Full Text] [Related]
19. ClearWayRX system to reduce intracoronary thrombus in patients with acute coronary syndromes according to optical coherence tomography after abciximab intracoronary local infusion trial (COCTAIL): study rationale and design.
Capodanno D; Prati F; Pawlowsky T; Ramazzotti V; Albertucci J; La Manna A; Robert G; Tamburino C
J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):130-6. PubMed ID: 19829141
[TBL] [Abstract][Full Text] [Related]
20. Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors.
De Carlo M; Maselli D; Cortese B; Ciabatti N; Gistri R; Levantino M; Balbarini A; De Caterina R; Petronio AS
Int J Cardiol; 2008 Jan; 123(3):229-33. PubMed ID: 17433463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
